Pharmagreen Biotech Inc. filed its 10-K on Jan 17, 2023 for the period ending Sep 30, 2022. In this report its auditor, Sadler, Gibb and Associates, LLC, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0008 USD | 0.00% | 0.00% | +33.33% |
1st Jan change | Capi. | |
---|---|---|
+33.33% | 531K | |
+21.94% | 46.93B | |
+37.63% | 39.08B | |
-8.38% | 38.48B | |
+30.51% | 31.01B | |
-13.75% | 26.14B | |
+11.28% | 25.88B | |
+35.86% | 12.53B | |
-6.43% | 11.36B | |
-12.31% | 10.65B |
- Stock Market
- Equities
- PHBI Stock
- News Pharmagreen Biotech Inc.
- Pharmagreen Biotech Inc. Auditor Raises 'Going Concern' Doubt